Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,267 | 404 | 98.8% |
| Education | $111.55 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,421 | 68 | $0 (2024) |
| Novo Nordisk Inc | $1,191 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,139 | 60 | $0 (2024) |
| Amgen Inc. | $1,013 | 36 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $475.37 | 15 | $0 (2022) |
| Lilly USA, LLC | $375.82 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $318.52 | 10 | $0 (2024) |
| Horizon Therapeutics plc | $304.76 | 20 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $244.61 | 13 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $200.01 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,910 | 86 | AstraZeneca Pharmaceuticals LP ($570.53) |
| 2023 | $1,762 | 91 | ABBVIE INC. ($432.50) |
| 2022 | $1,497 | 61 | Novo Nordisk Inc ($330.81) |
| 2021 | $900.51 | 46 | AbbVie Inc. ($292.72) |
| 2020 | $724.90 | 36 | Amgen Inc. ($217.57) |
| 2019 | $647.92 | 29 | Novo Nordisk Inc ($184.22) |
| 2018 | $944.83 | 24 | Amgen Inc. ($166.17) |
| 2017 | $990.83 | 33 | Ferring Pharmaceuticals Inc. ($182.91) |
All Payment Transactions
406 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/26/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | Bioventus LLC | SUPARTZ FX SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: DEVICES | ||||||
| 11/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $32.69 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Obesity | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $30.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 2,437 | 3,588 | $745,453 | $283,175 |
| 2022 | 38 | 2,232 | 4,602 | $706,094 | $284,673 |
| 2021 | 33 | 1,478 | 4,070 | $549,397 | $231,841 |
| 2020 | 26 | 1,174 | 2,051 | $484,107 | $170,598 |
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 347 | 672 | $168,250 | $75,344 | 44.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 183 | 183 | $69,000 | $27,888 | 40.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 213 | $63,900 | $23,679 | 37.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 66 | 195 | $39,600 | $18,072 | 45.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 159 | 215 | $43,000 | $16,348 | 38.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 81 | $48,600 | $13,113 | 27.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 13 | 44 | $26,400 | $8,860 | 33.6% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2023 | 54 | 54 | $16,200 | $7,854 | 48.5% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2023 | 20 | 75 | $45,000 | $7,528 | 16.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 44 | $13,200 | $6,998 | 53.0% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 56 | 56 | $22,400 | $6,460 | 28.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 78 | 78 | $9,360 | $6,088 | 65.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 62 | 62 | $21,700 | $5,812 | 26.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 40 | 53 | $18,550 | $5,705 | 30.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 64 | 84 | $6,720 | $4,565 | 67.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 21 | 22 | $9,900 | $4,404 | 44.5% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 56 | 56 | $16,800 | $4,368 | 26.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 21 | 44 | $8,800 | $3,883 | 44.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 69 | 84 | $6,100 | $3,843 | 63.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 19 | 19 | $9,500 | $3,704 | 39.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 47 | 49 | $4,635 | $3,602 | 77.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 39 | $7,800 | $2,884 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $7,600 | $2,585 | 34.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 199 | 210 | $13,650 | $2,571 | 18.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 111 | 111 | $2,775 | $2,450 | 88.3% |
About Ariel Nassim
Ariel Nassim is a Internal Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2012. The National Provider Identifier (NPI) number assigned to this provider is 1780959866.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ariel Nassim has received a total of $9,379 in payments from pharmaceutical and medical device companies, with $1,910 received in 2024. These payments were reported across 406 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($9,267).
As a Medicare-enrolled provider, Nassim has provided services to 7,321 Medicare beneficiaries, totaling 14,311 services with total Medicare billing of $970,287. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Sports Medicine
- Location Great Neck, NY
- Active Since 03/21/2012
- Last Updated 11/28/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1780959866
Products in Payments
- UBRELVY (Drug) $865.49
- FARXIGA (Drug) $638.94
- Ozempic (Drug) $609.33
- EUFLEXXA (Device) $475.37
- Otezla (Drug) $371.20
- AIRSUPRA (Drug) $345.01
- PENNSAID (Drug) $322.26
- QULIPTA (Drug) $307.37
- Repatha (Biological) $294.16
- JARDIANCE (Drug) $270.88
- Aimovig (Biological) $263.79
- Rybelsus (Drug) $244.94
- VRAYLAR (Drug) $216.30
- JANUVIA (Drug) $203.64
- NURTEC ODT (Drug) $183.17
- TRULICITY (Drug) $177.96
- MOUNJARO (Drug) $177.26
- XIFAXAN (Drug) $164.59
- Zilretta (Drug) $153.51
- ORTHOVISC (Device) $137.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Great Neck
Dr. Jamie Hirsch, Md, MD
Internal Medicine — Payments: $69,165
Joanne Lee, M.d, M.D
Internal Medicine — Payments: $36,469
Bernard Rosof
Internal Medicine — Payments: $26,679
Dr. Shahram Shamekh, Md, MD
Internal Medicine — Payments: $18,187
Sanford Ratner, M.d, M.D
Internal Medicine — Payments: $16,933
David Edelson, Md, MD
Internal Medicine — Payments: $15,163